Factors Determining Primary Coronary Slow Flow Phenomenon among Opium Users and Non-users: A Case Control Study in Northern Iran

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 61

This Paper With 5 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_AHJK-14-3_009

تاریخ نمایه سازی: 9 مرداد 1403

Abstract:

Background: Coronary slow flow phenomenon (CSFP) represents a clinical entity with recurrent chest pain leading to living impairment. The present study aimed to investigate whether opium use correlates with primary CSFP. Methods: This study included Iranian patients with suspected coronary artery disease who underwent myocardial perfusion imaging. Coronary blood flow was measured quantitatively using the thrombolysis in myocardial infarction (TIMI) frame count and slow flow was defined as TIMI grade ۲ standard deviations. Age and clinical conditions including diabetes mellitus (DM), hypertension (HTN), hyperlipidemia (HLP), history of chest pain, and opium use were recorded. First, the characteristics of the two groups were compared and then the main analyses were conducted to examine the relationship between CSFP and opium use. Data were analyzed using t test and chi-square test via SPSS ۲۵.۰. The significance level was set at P<۰.۰۵. Findings: This study was conducted on ۴۴ male patients with documented CSFP who had no stenotic lesions and ۱۳۴ control group male patients who had normal coronary arteries with normal flow. The mean age was similar in the two groups (۵۴.۲۵ vs.۵۲.۶۹, P=۰.۴۷۴). Two groups were significantly different in terms of history of chest pain (P=۰.۰۰۳), but there was no significant difference in HTN (P=۰.۰۸۴), DM (P=۰.۲۸۴), HLP (P=۰.۱۸۳), smoking (P=۰.۶۹۶), and opium use (P=۰.۱۰۷).  Conclusion: This study indicated that opium use is not associated with primary CSFP.

Authors

Hamid Reza Javadi

Department of Cardiology, Bu Ali Hospital, Qazvin University of Medical Sciences, Qazvin, Iran

Seyed Mostafa Mirakbari

Department of Clinical Toxicology, Bu Ali Hospital, Qazvin University of Medical Sciences, Qazvin, Iran

Abbas Allami

Department of Infectious Diseases, Bu Ali Hospital, Qazvin University of Medical Sciences, Qazvin, Iran

Ebrahim Salavati

Department of Cardiology, Bu Ali Hospital, Qazvin University of Medical Sciences, Qazvin, Iran